Right and left ventricular myocardial perfusion reserves correlate with right ventricular function and pulmonary hemodynamics in patients with pulmonary arterial hypertension

Radiology

Volumn 258, Issue 1, 2011, Pages 119-127

  Vogel Claussen, Jens ^a,e   Skrok, Jan ^a   Shehata, Monda L ^a   Singh, Sukhminder ^b   Sibley, Christopher T ^c   Boyce, Danielle M ^b   Lechtzin, Noah ^b   Girgis, Reda E ^b   Mathai, Steven C ^b   Goldstein, Thomas A ^d   Zheng, Jie ^d   Lima, João A C ^a   Bluemke, David A ^c   Hassoun, Paul M ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University School of Medicine   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; GADOLINIUM PENTETATE;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HEART CATHETERIZATION; HEART EJECTION FRACTION; HEART LEFT VENTRICLE; HEART MUSCLE PERFUSION; HEART RIGHT VENTRICLE; HEART VENTRICLE FUNCTION; HEMODYNAMIC PARAMETERS; HUMAN; IDIOPATHIC DISEASE; KRUSKAL WALLIS TEST; LUNG ARTERY PRESSURE; LUNG HEMODYNAMICS; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; SCLERODERMA;

ADENOSINE; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; HEART CATHETERIZATION; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SCLERODERMA, SYSTEMIC; STATISTICS, NONPARAMETRIC; VASODILATOR AGENTS; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 78650592865     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.10100725     Document Type: Article

References (38)

1. Voelkel NF, Quaife RA, Leinwand LA, et al. Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure. Circulation 2006; 514(17):1883-1891.
2. McLaughlin VV, Archer SL, Badesch DB, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians, American Thoracic Society, and the Pulmonary Hypertension Association. J Am Coll Cardiol 2009;53(17):1573-1619.
3. Humbert M, Sitbon O, Chaouat A, et al. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med 2006;573(9):1023-1030.
4. Ferlinz J. Right ventricular function in adult cardiovascular disease. Prog Cardiovasc Dis 1982;55(3):225-267.
5. Manohar M, Bisgard GE, Bullard V, Rankin JH. Blood flow in the hypertrophied right ventricular myocardium of unanesthetized ponies. Am J Physiol 1981;540(6):H881-H888.
6. van Wolferen SA, Marcus JT, Westerhof N, et al. Right coronary artery flow impairment in patients with pulmonary hypertension. Eur Heart J 2008;59(1):120-127.
7. Akasaka T, Yoshikawa J, Yoshida K, Hozumi T, Takagi T, Okura H. Comparison of relation of systolic flow of the right coronary artery to pulmonary artery pressure in patients with and without pulmonary hypertension. Am J Cardiol 1996;58(2):240-244.
8. Murray PA, Vatner SF. Reduction of maximal coronary vasodilator capacity in conscious dogs with severe right ventricular hypertrophy. Circ Res 1981;58(1):25-33.
9. Gómez A, Bialostozky D, Zajarias A, et al. Right ventricular ischemia in patients with primary pulmonary hypertension. J Am Coll Cardiol 2001;58(4):1137-1142.
10. Abuhid IM, de Rezende NA. Right ventricular wall "ischemia" findings using a dual isotope protocol. Clin Nucl Med 2007;52(8):652-654.
11. Taichman DB, Mandel J. Epidemiology of pulmonary arterial hypertension. Clin Chest Med 2007;58(1):1-22, vii.
12. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998;57(18):1837-1847.
13. Simonneau G, Galiè N, Rubin LJ, et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004;53(12 suppl S):5S-12S.
14. Mathai SC, Bueso M, Hummers LK, et al. Disproportionate elevation of N-terminal pro-brain natriuretic peptide in sclerodermarelated pulmonary hypertension. Eur Respir J 2010;55(1):95-104.
15. Klumpp B, Fenchel M, Hoevelborn T, et al. Assessment of myocardial viability using delayed enhancement magnetic resonance imaging at 3.0 Tesla. Invest Radiol 2006;51(9):661-667.
16. Christian TF, Bell SP, Whitesell L, Jerosch-Herold M. Accuracy of cardiac magnetic resonance of absolute myocardial blood flow with a high-field system: comparison with conventional field strength. JACC Cardiovasc Imaging 2009;5(9):1103-1110.
17. Axel L. Tissue mean transit time from dynamic computed tomography by a simple deconvolution technique. Invest Radiol 1983;58(1):94-99.
18. Jerosch-Herold M, Wilke N, Stillman AE. Magnetic resonance quantification of the myocardial perfusion reserve with a Fermi function model for constrained deconvolution. Med Phys 1998;55(1):73-84.
19. Goldstein TA, Jerosch-Herold M, Misselwitz B, Zhang H, Gropler RJ, Zheng J. Fast mapping of myocardial blood flow with MR firstpass perfusion imaging. Magn Reson Med 2008;59(6):1394-1400.
20. Goldstein TA, Zhang H, Misselwitz B, Gropler RG, Zheng J. Improvement of quantification of myocardial first-pass perfusion mapping: a temporal and spatial wavelet denoising method. Magn Reson Med 2006;56(2):439-445.
21. Plein S, Kozerke S, Suerder D, et al. High spatial resolution myocardial perfusion cardiac magnetic resonance for the detection of coronary artery disease. Eur Heart J 2008;59:2148-2155.
22. Selvanayagam JB, Jerosch-Herold M, Porto I, et al. Resting myocardial blood flow is impaired in hibernating myocardium: a magnetic resonance study of quantitative perfusion assessment. Circulation 2005;512(21):3289-3296.
23. Czernin J, Müller P, Chan S, et al. Influence of age and hemodynamics on myocardial blood flow and flow reserve. Circulation 1993;58(1):62-69.
24. Selvanayagam JB, Cheng AS, Jerosch-Herold M, et al. Effect of distal embolization on myocardial perfusion reserve after percutaneous coronary intervention: a quantitative magnetic resonance perfusion study. Circulation 2007;516(13):1458-1464.
25. Levin JR, Serlin RC, Seaman MA. A controlled, powerful multiple-comparison strategy for several situations. Psychol Bull 1994;515(1):153-159.
26. Fisher RA. The design of experiments. Edinburgh, Scotland: Oliver & Boyd, 1935.
27. Lin LI. A concordance correlation coefficient to evaluate reproducibility. Biometrics 1989;55(1):255-268.
28. Peled N, Bendayan D, Shitrit D, Fox B, Yehoshua L, Kramer MR. Peripheral endothelial dysfunction in patients with pulmonary arterial hypertension. Respir Med 2008;502(12):1791-1796.
29. Peled N, Shitrit D, Fox BD, et al. Peripheral arterial stiffness and endothelial dysfunction in idiopathic and scleroderma associated pulmonary arterial hypertension. J Rheumatol 2009;56(5):970-975.
30. Wolff B, Lodziewski S, Bollmann T, Opitz CF, Ewert R. Impaired peripheral endothelial function in severe idiopathic pulmonary hypertension correlates with the pulmonary vascular response to inhaled iloprost. Am Heart J 2007;553(6):1088.e1-1088.e7.
31. Nitenberg A, Foult JM, Kahan A, et al. Reduced coronary flow and resistance reserve in primary scleroderma myocardial disease. Am Heart J 1986;512(2):309-315.
32. Kahan A, Allanore Y. Primary myocardial involvement in systemic sclerosis. Rheumatology (Oxford) 2006;55(suppl 4):iv14-iv17.
33. Allanore Y, Meune C, Kahan A. Systemic sclerosis and cardiac dysfunction: evolving concepts and diagnostic methodologies. Curr Opin Rheumatol 2008;50(6):697-702.
34. Bezante GP, Rollando D, Sessarego M, et al. Cardiac magnetic resonance imaging detects subclinical right ventricular impairment in systemic sclerosis. J Rheumatol 2007;54(12):2431-2437.
35. Hachulla AL, Launay D, Gaxotte V, et al. Cardiac magnetic resonance imaging in systemic sclerosis: a cross-sectional observational study of 52 patients. Ann Rheum Dis 2009;58(12):1878-1884.
36. Bogaard HJ, Abe K, Vonk Noordegraaf A, Voelkel NF. The right ventricle under pressure: cellular and molecular mechanisms of right-heart failure in pulmonary hypertension. Chest 2009;535(3):794-804.
37. Plein S, Schwitter J, Suerder D, Greenwood JP, Boesiger P, Kozerke S. k-Space and time sensitivity encoding-accelerated myocardial perfusion MR imaging at 3.0 T: comparison with 1.5 T. Radiology 2008;549(2):493-500.
38. Klumpp BD, Seeger A, Doesch C, et al. High resolution myocardial magnetic resonance stress perfusion imaging at 3 T using a 1 M contrast agent. Eur Radiol 2010;50(3):533-541.